WIC
ICPT

Water Island Capital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Water Island Capital’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,650
Closed -$441K – 87
2019
Q3 		$441K Sell
6,650
-5,450
-45% -$366K 0.03% 59
2019
Q2 		$962K Buy
+12,100
New +$1.08M 0.02% 76

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Water Island Capital's ICPT Position: Q4 2019 in Review

Water Island Capital sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 6,650 shares — an estimated $441K sold.

Water Island Capital first reported a position in ICPT in Q2 2019 and held it in 2 quarters. The position peaked at $962K in Q2 2019. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

  • Water Island Capital reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • Water Island Capital sold 6,650 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $441K.
  • Water Island Capital first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2019 and held it in 2 quarters.
  • Water Island Capital's Intercept Pharmaceuticals, Inc. position peaked at $962K in Q2 2019.
  • 215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Water Island Capital's 13F filing for Q4 2019, filed 11 Feb 2020.